BF Biosciences Limited (PSX:BFBIO)
Pakistan flag Pakistan · Delayed Price · Currency is PKR
130.90
-1.72 (-1.30%)
At close: Nov 6, 2026

BF Biosciences Balance Sheet

Millions PKR. Fiscal year is Jul - Jun.

Assets

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Cash & Equivalents
178.27261.7344.47278.77255.44211.67
Short-Term Investments
411---147.391,498
Trading Asset Securities
-311.071,16739.01--
Cash & Short-Term Investments
589.27572.771,511317.78402.831,710
Cash Growth
-64.00%-62.10%375.55%-21.11%-76.44%34.58%
Accounts Receivable
535.69349.48184.24204.6193.8152.71
Other Receivables
-45.8745.5149.3349.64-
Receivables
535.69395.35229.75253.94143.4567.93
Inventory
3,0013,0521,740893.81852.24406.55
Prepaid Expenses
-6.595.345.882.28-
Other Current Assets
575.92418.63349.88205.26190.5110.93
Total Current Assets
4,7024,4463,8361,6771,5912,295
Property, Plant & Equipment
4,8734,6324,3064,1754,0702,135
Other Intangible Assets
6.387.233.980.551.11-
Other Long-Term Assets
96.6594.6911.857.834.834.83
Total Assets
9,6789,1808,1595,8605,6674,435

Liabilities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Accounts Payable
1,727288.42321.12269.06225.38394.28
Accrued Expenses
16.94910.77541.51266.09144.713.82
Short-Term Debt
309.97225.929.36328.7473.39149.35
Current Portion of Long-Term Debt
347.37342.07328.05292.72356.8857.65
Current Unearned Revenue
200.39144.6134.26150.87135.5999.86
Other Current Liabilities
-394.69269.97121.1567.02-
Total Current Liabilities
2,6022,3061,6241,4291,403714.96
Long-Term Debt
1,0021,0461,3671,5911,7721,537
Long-Term Unearned Revenue
192.38216.85318.37432.6503.73331.33
Long-Term Deferred Tax Liabilities
403.65316.99186.5848.3113.5126.55
Total Liabilities
4,1993,8863,4973,5003,6932,610

Shareholders' Equity

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Common Stock
265265265190190190
Additional Paid-In Capital
1,7801,7801,780---
Retained Earnings
3,4343,2492,6172,1701,7841,502
Comprehensive Income & Other
-----132.7
Shareholders' Equity
5,4795,2944,6622,3601,9741,825
Total Liabilities & Equity
9,6789,1808,1595,8605,6674,435

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Total Debt
1,6591,6141,7252,2122,6031,744
Net Cash (Debt)
-1,070-1,041-213.54-1,894-2,200-34.26
Net Cash Growth
------
Net Cash Per Share
-12.10-11.78-2.64-29.91-34.74-0.54
Filing Date Shares Outstanding
88.4688.3388.3363.3363.3363.33
Total Common Shares Outstanding
88.4688.3388.3363.3363.3363.33
Working Capital
2,1002,1392,212248.08188.341,580
Book Value Per Share
61.9459.9352.7837.2631.1728.82
Tangible Book Value
5,4735,2874,6582,3591,9731,825
Tangible Book Value Per Share
61.8659.8552.7337.2531.1528.82
Land
-25.3625.3625.3625.36-
Buildings
-993.57993.57236.06214.16-
Machinery
-4,3184,1311,191708.94-
Construction In Progress
-538.38133.033,5163,884-